AVITA Medical
(NASDAQ:RCEL)
$6.31
-0.21[-3.22%]
At close: Dec 6(Delayed 15-Minutes)
Get Real Time Here
$6.52
0.2100[3.33%]
After Hours: 4:43PM EDT
Day Range6.29 - 6.5352 Wk Range4.41 - 13.72Open / Close6.51 / 6.31Float / Outstanding24.8M / 25M
Vol / Avg.69.7K / 82.7KMkt Cap157.9MP/E-50d Avg. Price5.65
Div / Yield-Payout Ratio-Total Float24.8MEPS-0.22

AVITA Medical Stock (NASDAQ:RCEL), Quotes and News Summary

AVITA Medical Stock (NASDAQ: RCEL) stock price, news, charts, stock research, profile.

Loading...
Day Range6.29 - 6.5352 Wk Range4.41 - 13.72Open / Close6.51 / 6.31Float / Outstanding24.8M / 25M
Vol / Avg.69.7K / 82.7KMkt Cap157.9MP/E-50d Avg. Price5.65
Div / Yield-Payout Ratio-Total Float24.8MEPS-0.22
Globe Newswire - Nov 16, 2022, 9:00PM
Newsfile - Sep 19, 2022, 5:27PM
Globe Newswire - Sep 13, 2022, 4:11PM
InvestorsObserver - Aug 15, 2022, 7:56AM
TipRanks - May 12, 2022, 8:55PM
Seeking Alpha - Feb 17, 2022, 4:21PM
Seeking Alpha - Dec 21, 2021, 8:30AM
Sector: Health Care.Industry: Biotechnology
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.340-0.220 0.1200
REV7.030M9.092M2.062M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy AVITA Medical (RCEL) stock?

A

You can purchase shares of AVITA Medical (NASDAQ: RCEL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AVITA Medical's (RCEL) competitors?

Q

What is the target price for AVITA Medical (RCEL) stock?

A

The latest price target for AVITA Medical (NASDAQ: RCEL) was reported by Piper Sandler on Tuesday, March 2, 2021. The analyst firm set a price target for 27.00 expecting RCEL to rise to within 12 months (a possible 327.89% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for AVITA Medical (RCEL)?

A

The stock price for AVITA Medical (NASDAQ: RCEL) is $6.31 last updated Today at December 6, 2022, 9:00 PM UTC.

Q

Does AVITA Medical (RCEL) pay a dividend?

A

There are no upcoming dividends for AVITA Medical.

Q

When is AVITA Medical (NASDAQ:RCEL) reporting earnings?

A

AVITA Medical’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is AVITA Medical (RCEL) going to split?

A

There is no upcoming split for AVITA Medical.

Q

What sector and industry does AVITA Medical (RCEL) operate in?

A

AVITA Medical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.